The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lappe Mark since 2008.
This trader's CIK number is 1366074.
At the time of last reporting, Lappe Mark was the Chief Executive Officer of Inhibrx Biosciences, Inc.. (stock ticker symbol INBX).
Also see all insider trading activities at Inhibrx Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | RPRX | 0 | $0 | 1,197,000 | $852,042 | 0 | $0 |
| 2008 | RPRX | 2,044,180 | $13,326,177 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | INBX | 164,000 | $2,418,747 | 0 | $0 | 0 | $0 |
2. Inhibrx Biosciences, Inc. (INBX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-12-01 | RPRX | Sale | 131,000 | .71 | 92,748 |
| 2009-11-30 | RPRX | Sale | 148,000 | .71 | 105,524 |
| 2009-12-02 | RPRX | Sale | 262,000 | .70 | 182,352 |
| 2009-11-19 | RPRX | Sale | 214,000 | .75 | 160,286 |
| 2009-11-20 | RPRX | Sale | 215,000 | .71 | 152,005 |
| 2009-11-23 | RPRX | Sale | 227,000 | .70 | 159,127 |
| 2008-10-31 | RPRX | Buy | 11,300 | 7.76 | 87,688 |
| 2008-10-28 | RPRX | Buy | 9,892 | 6.87 | 67,958 |
| 2008-10-29 | RPRX | Buy | 24,400 | 6.97 | 170,068 |
| 2008-10-24 | RPRX | Buy | 30,000 | 6.89 | 206,700 |
| 2008-10-23 | RPRX | Buy | 17,309 | 6.32 | 109,392 |
| 2008-10-27 | RPRX | Buy | 14,825 | 6.85 | 101,551 |
| 2008-10-17 | RPRX | Buy | 30,000 | 6.42 | 192,600 |
| 2008-10-17 | RPRX | Buy | 30,000 | 6.42 | 192,600 |
| 2008-10-10 | RPRX | Buy | 15,300 | 6.23 | 95,319 |
| 2008-10-13 | RPRX | Buy | 15,000 | 6.82 | 102,300 |
| 2008-10-02 | RPRX | Buy | 1,846,154 | 6.50 | 12,000,001 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-16 | INBX | Buy | 13,037 | 17.13 | 223,323 |
| 2024-09-12 | INBX | Buy | 26,963 | 15.05 | 405,793 |
| 2024-09-06 | INBX | Buy | 26,000 | 15.29 | 397,540 |
| 2024-09-09 | INBX | Buy | 9,500 | 15.21 | 144,495 |
| 2024-09-10 | INBX | Buy | 8,500 | 15.19 | 129,115 |
| 2024-09-03 | INBX | Buy | 20,000 | 15.98 | 319,700 |
| 2024-08-30 | INBX | Buy | 10,000 | 14.02 | 140,200 |
| 2024-08-29 | INBX | Buy | 10,000 | 14.03 | 140,300 |
| 2024-08-20 | INBX | Buy | 27,055 | 12.97 | 350,903 |
| 2024-08-21 | INBX | Buy | 12,945 | 12.93 | 167,378 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lappe Mark (Chief Executive Officer of Inhibrx Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.